| Literature DB >> 27239860 |
E S Starodubova1,2, Y V Kuzmenko1, A A Latanova1, O V Preobrazhenskaya1, V L Karpov1.
Abstract
An optimized design of the rabies virus glycoprotein (G protein) for use within DNA vaccines has been suggested. The design represents a territorially adapted antigen constructed taking into account glycoprotein amino acid sequences of the rabies viruses registered in the Russian Federation and the vaccine Vnukovo-32 strain. Based on the created consensus amino acid sequence, the nucleotide codon-optimized sequence of this modified glycoprotein was obtained and cloned into the pVAX1 plasmid (a vector of the last generation used in the creation of DNA vaccines). A twofold increase in this gene expression compared to the expression of the Vnukovo-32 strain viral glycoprotein gene in a similar vector was registered in the transfected cell culture. It has been demonstrated that the accumulation of modified G protein exceeds the number of the control protein synthesized using the plasmid with the Vnukovo-32 strain viral glycoprotein gene by 20 times. Thus, the obtained modified rabies virus glycoprotein can be considered to be a promising DNA vaccine antigen.Entities:
Keywords: DNA vaccine; Vnukovo-32; consensus amino acid sequence; glycoprotein; rabies virus
Mesh:
Substances:
Year: 2016 PMID: 27239860 DOI: 10.7868/S0026898416020245
Source DB: PubMed Journal: Mol Biol (Mosk) ISSN: 0026-8984